Pfizer says it has manufactured an opioid medication less likely to be abused, but the FDA says otherwise. (Photo: Getty Images)

It was too good to be true: Addiction-free opioids appear to still be a fantasy.

In the wake of a recent lab test, the Food and Drug Administration appears less likely to approve use of a painkiller that its manufacturer, New York City-based Pfizer Inc., is touting as being less vulnerable to abuse. The agency conducted a review of the drug, and found that oxycodone can still be extracted from the pills with solvents.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?

Jack Craver



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.